Dr. Clay Siegall is the founder, president, CEO, and chairman of Seattle Genetics located in Bothwell, WA. They are a global oncology biotechnology company that specializes in developing antibody-based treatments. They help patients with cancer and diseases with high mortality rates. He is a board member of the Directors of Alder Biopharmaceuticals and a successful author. His research focuses on targeting monoclonal antibodies, linker systems and cell killing agents for cancer. He has worked for Bristol-Meyers Squibb Pharmaceutical Research Institute and the National Cancer Institute. He attended the University of Maryland where he received his bachelor’s and George Washington University where he obtained his Ph.D. in genetics.
In addition, Dr. Seigall helped create a cancer treatment therapy that was approved by the Food and Drug Administration called ADCETRIS (brentuximab vedotin). He developed over 20 medications that have improved the lives of patients. He has contributed to the financial growth of his company and has raised over $675 million in funds to ensure continued research opportunities. He is interested in making advancements in the pharmaceutical field and dedicated to finding an alternative treatment for cancer that does not include chemotherapy. He believes that chemotherapy is an outdated form of treatment as does not help improve patients’ health.
After watching his father die from cancer, Dr. Clay Seigall decided to pursue his education in the genetics industry. He had a desire to make advancements in cancer treatment and produce options that were not available. He now has over 30 years of experience in pharmaceutical development and is a leader in his field. He is passionate about his work and looks forward to helping people suffering from diseases that are difficult to cure. He works with other professionals and has partnered with Bayer, Genentech, and Pfizer to help develop medications. He believes in creating strategies that are innovative and will improve the quality of life for patients.
Dr. Seigall has initiated many ground-breaking therapies for cancer treatment. He is determined to change the medical procedures for hard to cure diseases. He will change the course of medication and help many achieve better health.